Medical Foods Market Share, Demand, Covid-19 Impact Analysis, Forecast Till 2030

Medical Foods Market- By Application, By Type, By Sales Channel -Regional Outlook, Competitive Strategies and Segment Forecast to 2030

Medical Foods Market- By Application, By Type, By Sales Channel -Regional Outlook, Competitive Strategies and Segment Forecast to 2030

Published: Aug 2022 Report ID: HLCA2206 Pages: 1 - 249 Formats*:     
Category : Healthcare
Global Medical Foods Market Overview:

According to SPER Market Research, the Global Medical Foods Market is estimated to reach USD 34.32 billion by 2030 with a CAGR of 5.5%. The medical foods market consists of sales of medical foods by entities (organizations, sole traders, and partnerships) that refer to foods, which are formulated to be administered or consumed under the presence of a physician, and it is intended to provide specific dietary management of a disease for which nutritional requirements are established by medical evaluation. Medical food pills are specially formulated to meet the nutritional requirements of patients with various medical conditions such as digression, ADHD, and others. They are used in the treatment of Alzheimer’s disease, Diabetic Neuropathy, Nutritional Deficiency, ADHD, and others. As people get old, their dependency on certain nutritional foods increases especially medical foods to manage their health from chronic and age-related diseases. 

The companies operating in the medical foods sector are developing innovative products with greater efficacy to cater to the demand from customers with specific niche diseases such as metabolic disorders, ADHD, and others. 

Major players in the medical foods market are Nestle, Fresenius Se & Co., Danone, Primus Pharmaceuticals Inc., Abbott Laboratories, Metagenics Inc., Targeted Medical Pharma Inc.

Impact of COVID-19 on the Global Medical Foods Market:
The report delivers insights on COVID-19 considering the changes in consumer behaviour and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments.

Scope of the report:
 Report Metric Details
 Market size available for years 2019-2030
 Base year considered 2021
 Forecast period 2022-2030
 Segments coveredBy Application, By Type, By Sales Channel, By Region
 Geographies coveredNorth America, Europe, Asia Pacific, Latin America, Middle East, Africa
 Companies CoveredAbbott Laboratories, Cerecin Inc., Danone, Fresenius SE & Co., Meiji Holdings and Co. Ltd., Metagenics Inc., Nestle, Primus Pharmaceuticals Inc., Reckitt Benckiser Group, Targeted Medical Pharma Inc.

Global Medical Foods Market Segmentation:

By Application: Based on the application, Global Medical Foods Market is segmented as; Alzheimer's Disease, Diabetic Neuropathy, Nutritional Deficiency, ADHD, Others.
By Type: Based on the type, Global Medical Foods Market is segmented as; Pills, Powder, Others.

By Sales Channel: Based on the sales channel, Global Medical Foods Market is segmented as; Retail Sales, Online Sales, Institutional Sales. 
By Region: North America was the largest region in the medical foods market. Asia-Pacific is expected to be the fastest-growing region in the global medical foods market during the forecast period.

1. Introduction
1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology
2.1 Research data source
2.1.1. Secondary data
2.1.2. Primary data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2 Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges 
4.2. COVID-19 Impacts of the Global Medical Foods Market 

5. Market variables and outlook
5.1. SWOT analysis 
5.1.1. Strengths 
5.1.2. Weaknesses 
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL analysis 
5.2.1. Political landscape
5.2.2. Economic landscape
5.2.3. Social landscape 
5.2.4. Technological landscape 
5.2.5. Environmental landscape 
5.2.6. Legal landscape 
5.3. PORTER’S five forces analysis 
5.3.1. Bargaining power of suppliers 
5.3.2. Bargaining power of Buyers 
5.3.3.Threat of Substitute 
5.3.4. Threat of new entrant 
5.3.5. Competitive rivalry
5.4. Heat map analysis

6. Global Medical Foods Market, By Application, 2019-2030 (USD Million)
6.1. Alzheimer’s Disease
6.2. Diabetic Neuropathy 
6.3. Nutritional Deficiency
6.4. ADHD
6.5. Others
7. Global Medical Foods Market, By Type, 2019-2030 (USD Million)
7.1. Pills 
7.2. Powder 
7.3. Others

8. Global Medical Foods Market, By Sales Channel, 2019-2030 (USD Million)
8.1. Retail Sales 
8.2. Online Sales 
8.3. Institutional Sales 

9. Global Medical Foods Market, By Region, 2019-2030 (USD Million)
9.1. North America
9.1.1. United States
9.1.2. Canada
9.1.3. Mexico
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Australia
9.3.5. South Korea
9.3.6. Rest of Asia-Pacific
9.4. South America
9.4.1. Brazil
9.4.2. Argentina
9.4.3. Rest of South America
9.5. Middle East & Africa
9.5.1. Kingdom of Saudi Arabia 
9.5.2. United Arab Emirates
9.5.3. Rest of Middle East & Africa

10. Company Profiles
10.1. Abbott Laboratories 
10.1.1. Company details 
10.1.2. Financial outlook
10.1.3. Product summary 
10.1.4. Recent developments
10.2. Cerecin Inc. 
10.2.1. Company details 
10.2.2. Financial outlook
10.2.3. Product summary 
10.2.4. Recent developments
10.3. Danone 
10.3.1. Company details 
10.3.2. Financial outlook
10.3.3. Product summary 
10.3.4. Recent developments
10.4. Fresenius SE & Co. 
10.4.1. Company details 
10.4.2. Financial outlook
10.4.3. Product summary 
10.4.4. Recent developments
10.5. Meiji Holdings & Co. Ltd. 
10.5.1. Company details 
10.5.2. Financial outlook
10.5.3. Product summary 
10.5.4. Recent developments
10.6. Metagenics Inc.
10.6.1. Company details 
10.6.2. Financial outlook
10.6.3. Product summary 
10.6.4. Recent developments
10.7. Nestle 
10.7.1. Company details 
10.7.2. Financial outlook
10.7.3. Product summary 
10.7.4. Recent developments
10.8. Primus Pharmaceuticals Inc.
10.8.1. Company details 
10.8.2. Financial outlook
10.8.3. Product summary 
10.8.4. Recent developments
10.9. Reckitt Benckiser Group 
10.9.1. Company details
10.9.2. Financial outlook
10.9.3. Product summary
10.9.4. Recent developments
10.10. Targeted Medical Pharma Inc. 
10.10.1. Company details 
10.10.2. Financial outlook
10.10.3. Product summary 
10.10.4. Recent developments

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.




Not able to find what you are looking for? Need customization in the existing report?
Click Here
  • 15% off
    $ 4250
  • 20% off
    $ 5650
  • 25% off
    $ 7450
Pre-Purchase Inquiry
Request Customization
100% Secure Payment

SPER American Express
SPER Master Card
SPER Mestro
SPER Paypal
SPER CCAvenues

Join Our SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Johnson & Johnson


Market Research

We are the leading, full-service global market research and consulting company.

iso-1 iso-1 iso-1 ESOMAR
Secure Payments
SPER Payment Options
Contact HR

 [email protected]